Search for: "Mylan, Inc." Results 181 - 200 of 673
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 May 2012, 8:43 pm by Patent Docs
Mylan Pharmaceuticals, Inc. 0:12-cv-60704; filed April 20, 2012 in the Southern District of Florida • Plaintiffs: Apotex,... [read post]
21 Aug 2018, 9:58 pm by Patent Docs
Mylan Pharmaceuticals Inc., affirming the decision by the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
29 Aug 2004, 3:55 pm
West Virginia US District Judge Irene Keeley may rule as early as Monday on the legality of "authorized generics" in a dispute between the FDA and Mylan Laboratories, Inc.. [read post]
12 Apr 2017, 4:15 am by John M. Rogitz
Mylan, Inc. (2015-1113, 2015-1151, and 2015-1181) that imports certain subject matter from the specification into the claims... [read post]
29 Aug 2016, 5:02 am by Susanna Leighton
Just last week, Mylan Inc. decided it was a good idea to raise the price of the life-saving EpiPen, which is used to stop a person from going into anaphylactic shock after experiencing an allergic reaction. [read post]
10 Nov 2022, 1:25 pm by Mark Astarita
The Securities and Exchange Commission today announced insider trading charges against Ramkumar Rayapureddy, Chief Information Officer of pharmaceutical company Viatris Inc., which was formerly known as Mylan N.V. [read post]
4 Sep 2016, 8:42 am by Susanna Leighton
With the price increase of the live-saving EpiPen from $100 per two-pack to over $600 per two-pack last week (conveniently in August when most parents who have children with allergies are set to purchase their necessary supplies of the drug before school starts), the company responsible for the hike, Mylan Inc., is backing away fromThe post EpiPen Increase Based in Greed, Not Need appeared first on Legal Reader. [read post]